These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1826024

  • 1. Use of technetium-99m-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition.
    Dondi M, Monetti N, Fanti S, Marchetta F, Corbelli C, Zagni P, De Fabritis A, Losinno F, Levorato M, Zuccalá A.
    J Nucl Med; 1991 Mar; 32(3):424-8. PubMed ID: 1826024
    [Abstract] [Full Text] [Related]

  • 2. Captopril renal scintigraphy with 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) for detecting renal artery stenosis.
    Dondi M.
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):737S-740S. PubMed ID: 1837995
    [Abstract] [Full Text] [Related]

  • 3. Patients at high risk for renal artery stenosis: a simple method of renal scintigraphic analysis with Tc-99m DTPA and captopril.
    Chen CC, Hoffer PB, Vahjen G, Gottschalk A, Koster K, Zubal IG, Setaro JF, Roer DA, Black HR.
    Radiology; 1990 Aug; 176(2):365-70. PubMed ID: 2195592
    [Abstract] [Full Text] [Related]

  • 4. The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience.
    van Jaarsveld BC, Krijnen P, Derkx FH, Oei HY, Postma CT, Schalekamp MA.
    Arch Intern Med; 1997 Jun 09; 157(11):1226-34. PubMed ID: 9183234
    [Abstract] [Full Text] [Related]

  • 5. [99mTc-MAG3-kidney function scintigraphy without and with captopril in the diagnosis of renovascular hypertension].
    Piepenburg R, Bockisch A, Andreas J, Düber C, Kann P, Maier G, Hahn K.
    Rofo; 1993 Aug 09; 159(2):150-7. PubMed ID: 8353261
    [Abstract] [Full Text] [Related]

  • 6. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty.
    Müller-Suur R, Tidgren B, Fehrm A, Lundberg HJ.
    J Nucl Med; 2000 Jul 09; 41(7):1203-8. PubMed ID: 10914910
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation criteria for captopril-kidney function scintigraphy using 99mTc-MAG3].
    Piepenburg R, Bockisch A, Maier G, Düber C, Kann P, Hahn K.
    Nuklearmedizin; 1993 Dec 09; 32(6):306-15. PubMed ID: 8295828
    [Abstract] [Full Text] [Related]

  • 8. Captopril-enhanced scintigraphy using the method of the expected renogram: improved detection of patients with renin-dependent hypertension due to functionally significant renal artery stenosis.
    Roccatello D, Picciotto G.
    Nephrol Dial Transplant; 1997 Oct 09; 12(10):2081-6. PubMed ID: 9351069
    [Abstract] [Full Text] [Related]

  • 9. Captopril renal scintigraphy in patients with hypertension and chronic renal failure.
    Datseris IE, Bomanji JB, Brown EA, Nijran KS, Padhy AK, Siraj QH, Britton KE.
    J Nucl Med; 1994 Feb 09; 35(2):251-4. PubMed ID: 8294993
    [Abstract] [Full Text] [Related]

  • 10. [Diagnosis of renovascular hypertension by pre- and post-captopril renal scintigraphy with 99mTc-DMSA].
    Acosta Gómez MJ, Llamas Elvira JM, Rodríguez Fernández A, Gómez Río M, López Ruiz JM, Muros De Fuentes MA, Moral Ruiz A, Ramírez Navarro A.
    Rev Esp Med Nucl; 2001 Dec 09; 20(7):537-43. PubMed ID: 11709139
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Value of captopril renal scintigraphy in hypertensive patients with renal failure.
    Fernandez P, Morel D, Jeandot R, Potaux L, Basse-Cathalinat B, Ducassou D.
    J Nucl Med; 1999 Mar 09; 40(3):412-7. PubMed ID: 10086704
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Superiority of tc-99m MAG3 to tc-99m DTPA in treating a patient with mild renal artery stenosis.
    Kiratli PO, Caner B, Altun B, Cekirge S.
    Ann Nucl Med; 2001 Feb 09; 15(1):45-8. PubMed ID: 11355781
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of renovascular hypertension: feasibility of captopril-sensitized dynamic MR imaging and comparison with captopril scintigraphy.
    Grenier N, Trillaud H, Combe C, Degrèze P, Jeandot R, Gosse P, Douws C, Palussière J.
    AJR Am J Roentgenol; 1996 Apr 09; 166(4):835-43. PubMed ID: 8610560
    [Abstract] [Full Text] [Related]

  • 16. Aspirin renography and captopril renography in the diagnosis of renal artery stenosis.
    van de Ven PJ, de Klerk JM, Mertens IJ, Koomans HA, Beutler JJ.
    J Nucl Med; 2000 Aug 09; 41(8):1337-42. PubMed ID: 10945524
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of hypertensive patients with a solitary kidney using captopril renal scintigraphy with 99Tcm-MAG3.
    Fanti S, Dondi M, Corbelli C, Zagni P, Bellanova B, Franchi R, Levorato M, Fallani F, Marengo M, Fagioli G.
    Nucl Med Commun; 1993 Nov 09; 14(11):969-75. PubMed ID: 8290169
    [Abstract] [Full Text] [Related]

  • 18. Captopril renography. Early observations and diagnostic criteria.
    Oei HY.
    Am J Hypertens; 1991 Dec 09; 4(12 Pt 2):678S-684S. PubMed ID: 1837990
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of captopril renal scintigraphy in renovascular hypertension.
    Dondi M, Fanti S, De Fabritiis A, Zuccala A, Gaggi R, Mirelli M, Stella A, Marengo M, Losinno F, Monetti N.
    J Nucl Med; 1992 Nov 09; 33(11):2040-4. PubMed ID: 1432170
    [Abstract] [Full Text] [Related]

  • 20. Captopril-enhanced 99Tcm-MAG3 renal scintigraphy in subjects with suspected renovascular hypertension.
    Kahn D, Ben-Haim S, Bushnell DL, Madsen MT, Kirchner PT.
    Nucl Med Commun; 1994 Jul 09; 15(7):515-28. PubMed ID: 7970428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.